DexCom, Inc.DXCM

$72.47+1.24 (+1.74%)

NASDAQHealthcare24:00 UTC

Company snapshot

Market Cap

$29B

Large-cap

+363%

2016 — today

10-Year Price

+287%

2016 — today

52-Week Range

$54.84$89.53

Current $72.47· 51%

DexCom develops and markets continuous glucose monitoring (CGM) systems for diabetes management globally. Its portfolio includes the G6 system, Dexcom ONE, and the G7 next-generation CGM. The firm also offers the Real-Time API for third-party digital health integration and the Dexcom Share remote monitoring platform. DexCom collaborates with Verily Life Sciences to advance glucose monitoring technology. Products are sold directly to endocrinologists, physicians, and diabetes educators. Founded in 1999, it is based in San Diego.